Cfo4 Life Group, LLC Laboratory Corp Of America Holdings Transaction History

Cfo4 Life Group, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$213.86 - $277.87 $485,889 - $631,320	-2,272 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$259.82 - $298.18 $13,250 - $15,207	51 Added 2.3%	2,272 $599,000
Q4 2021 Feb 10, 2022	BUY	$271.6 - $314.21 $31,505 - $36,448	116 Added 5.51%	2,221 $698,000
Q3 2021 Oct 12, 2021	BUY	$274.82 - $308.34 $578,496 - $649,055	2,105 New	2,105 $592,000
Q4 2018 Feb 01, 2019	SELL	$120.82 - $174.09 $380,341 - $548,035	-3,148 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$167.67 - $188.27 $34,540 - $38,783	206 Added 7.0%	3,148 $547,000
Q2 2018 Aug 01, 2018	SELL	$160.33 - $189.41 $20,842 - $24,623	-130 Reduced 4.23%	2,942 $528,000
Q1 2018 May 07, 2018	BUY	$161.53 - $178.11 $3,069 - $3,384	19 Added 0.62%	3,072 $497,000
Q4 2017 Jan 22, 2018	SELL	$147.99 - $163.95 $14,207 - $15,739	-96 Reduced 3.05%	3,053 $487,000
Q3 2017 Nov 09, 2017	BUY	$149.47 - $160.56 $14,498 - $15,574	97 Added 3.18%	3,149 $475,000
Q2 2017 Aug 08, 2017	BUY	N/A	3,052	3,052 $470,000

1.87M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $22.4B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Cfo4 Life Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Cfo4 Life Group, LLC with notifications on news.